Home
News
Create
Screeners
Insights
Beta Drugs
1,323.
70
+7.20
(+0.55%)
Market Cap
₹1,341.82 Cr
PE Ratio
32.18
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.55%
1M
+19.67%
6M
-27.28%
1Y
-30.76%
5Y
+729.91%
View Company Insights
Latest news about Beta Drugs
Beta Drugs Achieves Regulatory Milestones in Azerbaijan and Philippines Markets
9 hrs ago
Yesterday
Beta Drugs Limited has secured important regulatory achievements in Azerbaijan and Philippines markets. The company's manufacturing facility successfully completed GMP inspection by Azerbaijan's Ministry of Health from April 13-17, 2026, with approval expected within 1-2 months. In Philippines, the company received product registration certificates for 2 brands representing first generic approvals in their categories, with additional approvals anticipated within 6 months to support expansion into Vietnam and Thailand markets.
Beta Drugs Acquires 66% Stake in IVF Specialist Nivian Lifesciences for ₹69.4 Crore
Jan 12, 2026
Beta Drugs to Acquire 66.09% Stake in Nivian Life Sciences for ₹694 Million
Jan 09, 2026
Beta Drugs Secures Approval for Main Board Listing, Marking Significant Milestone
Nov 21, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO